Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted

Journal of Virology

Volumn 81, Issue 16, 2007, Pages 8722-8729

  Inoue, Yuuki ^a   Tanaka, Nobuyuki ^a,c   Tanaka, Yoshinori ^a   Inoue, Shingo ^b   Morita, Kouichi ^b   Zhuang, Min ^a   Hattori, Toshio ^a   Sugamura, Kazuo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; CAVEOLIN 1; CHLORPROMAZINE; CLATHRIN; DIPEPTIDYL CARBOXYPEPTIDASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL STRAIN COS7; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOPLASM; ENDOCYTOSIS; ENDOSOME; ENZYME LOCALIZATION; GENE SILENCING; GENETIC TRANSFECTION; HOST CELL; HUMAN; HUMAN CELL; INTERNALIZATION; MEMBRANE VESICLE; NONHUMAN; PH; PRIORITY JOURNAL; SARS CORONAVIRUS; TARGET CELL; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; WILD TYPE;

ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CHLORPROMAZINE; CLATHRIN; COS CELLS; CYTOPLASM; ENDOCYTOSIS; ENDOSOMES; HUMANS; PEPTIDYL-DIPEPTIDASE A; RNA, SMALL INTERFERING; SARS VIRUS; SEQUENCE DELETION; VIRUS INTERNALIZATION;

SARS CORONAVIRUS;

EID: 34547743810     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00253-07     Document Type: Article

References (44)

1. Ashraf, H. 2005. Cathepsin enzyme provides clue to SARS infection. Drug Discov. Today 10:1409.
2. Beer, C., D. S. Andersen, A. Rojek, and L. Pedersen. 2005. Caveola-dependent endocytic entry of amphotropic murine leukemia virus. J. Virol. 79:10776-10787.
3. Belleudi, F., V. Visco, M. Ceridono, L. Leone, R. Muraro, L. Frati, and M. R. Torrisi. 2003. Ligand-induced clathrin-mediated endocytosis of the keratinocyte growth factor receptor occurs independently of either phosphorylation or recruitment of eps15. FEBS Lett. 553:262-270.
4. Bousarghin, L., A. Touze, P. Y. Sizaret, and P. Coursaget. 2003. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J. Virol. 77:3846-3850.
5. Choi, K. S., H. Aizaki, and M. M. Lai. 2005. Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release. J. Virol. 79:9862-9871.
6. Damm, E. M., L. Pelkmans, J. Kartenbeck, A. Mezzacasa, T. Kurzchalia, and A. Helenius. 2005. Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 168:477-488.
7. Danthi, P., and M. Chow. 2004. Cholesterol removal by methyl-beta-cyclodextrin inhibits poliovirus entry. J. Virol. 78:33-41.
8. Empig, C. J., and M. A. Goldsmith. 2002. Association of the caveola vesicular system with cellular entry by filoviruses. J. Virol. 76:5266-5270.
9. Gembardt, F., A. Sterner-Kock, H. Imboden, M. Spalteholz, F. Reibitz, H. P. Schultheiss, W. E. Siems, and T. Walther. 2005. Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides 26:1270-1277.
10. Helenius, A., J. Kartenbeck, K. Simons, and E. Fries. 1980. On the entry of Semliki Forest virus into BHK-21 cells. J. Cell Biol. 84:404-420.
11. Hofmann, H., M. Geier, A. Marzi, M. Krumbiegel, M. Peipp, G. H. Fey, T. Gramberg, and S. Pohlmann. 2004. Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochem. Biophys. Res. Commun. 319:1216-1221.
12. Hommelgaard, A. M., K. Roepstorff, F. Vilhardt, M. L. Torgersen, K. Sandvig, and B. van Deurs. 2005. Caveolae: stable membrane domains with a potential for internalization. Traffic 6:720-724.
13. Huang, I. C., B. J. Bosch, F. Li, W. Li, K. H. Lee, S. Ghiran, N. Vasilieva, T. S. Dermody, S. C. Harrison, P. R. Dormitzer, M. Farzan, P. J. Rottier, and H. Choe. 2006. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J. Biol. Chem. 281:3198-3203.
14. Imelli, N., O. Meier, K. Boucke, S. Hemmi, and U. F. Greber. 2004. Cholesterol is required for endocytosis and endosomal escape of adenovirus type 2. J. Virol. 78:3089-3098.
15. Insel, P. A., B. P. Head, R. S. Ostrom, H. H. Patel, J. S. Swaney, C. M. Tang, and D. M. Roth. 2005. Caveolae and lipid rafts: G protein-coupled receptor signaling microdomains in cardiac myocytes. Ann. N. Y. Acad. Sci. 1047:166-172.
16. Kuhn, J. H., W. Li, H. Choe, and M. Farzan. 2004. Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus. Cell Mol. Life Sci. 61:2738-2743.
17. Kyuuma, M., K. Kikuchi, K. Kojima, Y. Sugawara, M. Sato, N. Mano, J. Goto, T. Takeshita, A. Yamamoto, K. Sugamura, and N. Tanaka. 2007. AMSH, an ESCRT-III associated enzyme, deubiquitinates cargo on MVB/late endosomes. Cell Struct. Funct. 31:159-172.
18. Lambert, S., D. Vind-Kezunovic, S. Karvinen, and R. Gniadecki. 2006. Ligand-independent activation of the EGFR by lipid raft disruption. J. Investig. Dermatol. 126:954-962.
19. Li, G. M., Y. G. Li, M. Yamate, S. M. Li, and K. Ikuta. 2007. Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle. Microbes Infect. 9:96-102.
20. Li, W., M. J. Moore, N. Vasilieva, J. Sui, S. K. Wong, M. A. Berne, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, T. C. Greenough, H. Choe, and M. Farzan. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454.
21. Marjomaki, V., V. Pietiainen, H. Matilainen, P. Upla, J. Ivaska, L. Nissinen, H. Reunanen, P. Huttunen, T. Hyypia, and J. Heino. 2002. Internalization of echovirus 1 in caveolae. J. Virol. 76:1856-1865.
22. Marsh, M., and A. Helenius. 2006. Virus entry: open sesame. Cell 124:729-740.
23. Mellman, I. 1996. Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 12:575-625.
24. Nawa, M., T. Takasaki, K. Yamada, I. Kurane, and T. Akatsuka. 2003. Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine. J. Gen. Virol. 84:1737-1741.
25. Nie, Y., P. Wang, X. Shi, G. Wang, J. Chen, A. Zheng, W. Wang, Z. Wang, X. Qu, M. Luo, L. Tan, X. Song, X. Yin, M. Ding, and H. Deng. 2004. Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression. Biochem. Biophys. Res. Commun. 321: 994-1000.
26. Nomura, R., A. Kiyota, E. Suzaki, K. Kataoka, Y. Ohe, K. Miyamoto, T. Senda, and T. Fujimoto. 2004. Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae. J. Virol. 78:8701-8708.
27. Pearse, B. M., C. J. Smith, and D. J. Owen. 2000. Clathrin coat construction in endocytosis. Curr. Opin. Struct. Biol. 10:220-228.
28. Pelkmans, L. 2005. Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses. Biochim. Biophys. Acta 1746:295-304.
29. Pelkmans, L., and A. Helenius. 2003. Insider information: what viruses tell us about endocytosis. Curr. Opin. Cell Biol. 15:414-422.
30. Pietiainen, V. M., V. Marjomaki, J. Heino, and T. Hyypia. 2005. Viral entry, lipid rafts and caveosomes. Ann. Med. 37:394-403.
31. Prabakaran, P., X. Xiao, and D. S. Dimitrov. 2004. A model of the ACE2 structure and function as a SARS-CoV receptor. Biochem. Biophys. Res. Commun. 314:235-241.
32. Riemann, D., G. H. Hansen, L. Niels-Christiansen, E. Thorsen, L. Immerdal, A. N. Santos, A. Kehlen, J. Langner, and E. M. Danielsen. 2001. Caveolae/lipid rafts in fibroblast-like synoviocytes: ectopeptidase-rich membrane microdomains. Biochem. J. 354:47-55.
33. Rodal, S. K., G. Skretting, O. Garred, F. Vilhardt, B. van Deurs, and K. Sandvig. 1999. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell 10:961-974.
34. Sha, Y., Y. Wu, Z. Cao, X. Xu, W. Wu, D. Jiang, X. Mao, H. Liu, Y. Zhu, R. Gong, and W. Li. 2006. A convenient cell fusion assay for the study of SARS-CoV entry and inhibition. IUBMB Life. 58:480-486.
35. Sieczkarski, S. B., and G. R. Whittaker. 2005. Characterization of the host cell entry of filamentous influenza virus. Arch. Virol. 150:1783-1796.
36. Sieczkarski, S. B., and G. R. Whittaker. 2003. Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4:333-343.
37. Simmons, G., D. N. Gosalia, A. J. Rennekamp, J. D. Reeves, S. L. Diamond, and P. Bates. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA 102:11876-11881.
38. Sorkin, A. 2004. Cargo recognition during clathrin-mediated endocytosis: a team effort. Curr. Opin. Cell Biol. 16:392-399.
39. Stang, E., F. D. Blystad, M. Kazazic, V. Bertelsen, T. Brodahl, C. Raiborg, H. Stenmark, and I. H. Madshus. 2004. Cbl-dependent ubiquitination is required for progression of EGF receptors into clathrin-coated pits. Mol. Biol. Cell 15:3591-3604.
40. Sun, X., V. K. Yau, B. J. Briggs, and G. R. Whittaker. 2005. Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology 338:53-60.
41. Yang, Z. Y., Y. Huang, L. Ganesh, K. Leung, W. P. Kong, O. Schwartz, K. Subbarao, and G. J. Nabel. 2004. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 78:5642-5650.
42. Yao, D., M. Ehrlich, Y. I. Henis, and E. B. Leof. 2002. Transforming growth factor-beta receptors interact with AP2 by direct binding to beta2 subunit. Mol. Biol. Cell 13:4001-4012.
43. Yu, F., M. Q. Le, S. Inoue, H. T. Thai, F. Hasebe, M. Del Carmen Parquet, and K. Morita. 2005. Evaluation of inapparent nosocomial severe acute respiratory syndrome coronavirus infection in Vietnam by use of highly specific recombinant truncated nucleocapsid protein-based enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 12:848-854.
44. Ziebuhr, J. 2004. Molecular biology of severe acute respiratory syndrome coronavirus. Curr. Opin. Microbiol. 7:412-419.